Gynecologic Oncology - Medical Oncologist

Description:

The Division of Gynecologic Oncology/ Department of Women’s Health at the Henry Ford Hospital & Henry Ford Cancer Institute (HFCI), in association with The Division of Hematology & Oncology in the Department of Internal Medicine at the Henry Ford Hospital & Henry Ford Cancer Institute (HFCI) is currently recruiting a full-time, board-certified Academic Medical Oncologist for its busy, well-established hospital-based, academic practice, with an established fellowship program in both hematology oncology as well as a gynecologic oncology. .  We are looking for individuals focused on Gynecologic Oncology and encourage applications from those with clinical or translational research interests in this field. The successful applicant will have a passion for and the ability to lead clinical trials as our institution pursues an NCI cancer designation.

HFCI is a destination site for ambulatory cancer treatment, precision medicine, clinical trials and research, and enhanced support services for cancer patients.  The Institute’s approach to operations provides for a robust hub and encompasses a team approach to cancer care, with multiple locations and providers who seamlessly communicate with each other and have access to advanced treatment options such as Precision Medicine, with satellites located throughout Metro Detroit and Southeast Michigan. The highly motivated team at HFCI utilizes a personalized, innovative, multidisciplinary approach to patient care, with a commitment to evidence-based practice and evaluation of outcomes.

The Division of Hematology & Oncology is an active member of SWOG, and oversees a comprehensive portfolio of cooperative group, investigator initiated, and industry sponsored clinical trials, with an active and growing Phase 1 program.

This person will join a multidisciplinary clinical team, in addition to Research, Psych-oncology & Supportive Oncology faculty, and APPs.  The Division is responsible for providing medical care to patients, teaching and supervising medical students, residents, and 17 fellows (between Hematology Oncology and Gynecology Oncology), and overseeing advanced care practitioners.

Qualifications:

• Must be board certified in Internal Medicine
• Must have completed an ACGME/AOA approved Hematology/Oncology Fellowship program.

Henry Ford Health partners with millions of people on their health journey, across Michigan and around the world. With former Ascension southeast Michigan and Flint area locations, Henry Ford now offers care in 550 locations, including 13 acute care hospitals, 3 behavioral health facilities (featuring 2 world-class addiction treatment centers), a state-of-the-art orthopedics and sports medicine facility, and multiple cancer care destinations, including the Brigitte Harris Cancer Pavilion in Detroit.

Our full continuum of services spans from primary and preventative care to complex and specialty care, complemented by a health insurance plan, home health offerings, virtual care, pharmacy, and eye care. Henry Ford Health is powered by 50,000 dedicated team members committed to delivering exceptional care and fostering innovation.

Based in Detroit, we're leading the Future of Health: Detroit initiative, a $3 billion investment centered on reimagining our academic healthcare campus. Our mission extends beyond patient care to include cutting-edge research and education, with a focus on innovation, population health, and complex care.

For those interested in joining our team, learn more about career opportunities at henryford.com/careers.

For more than 100 years, Henry Ford Hospital has been a leader in advancing medicine and delivering the most innovative treatments. This 877-bed academic hospital is recognized for clinical excellence, is staffed by the Henry Ford Medical Group and is recognized as a Level 1 Trauma Center and a Magnet® facility. “Destination Grand,” a $2.2 billion development underway, includes a vastly expanded Henry Ford Hospital, with a new hospital facility and patient tower to open in 2029.